Moreover, overexpression of TAZ reduced the levels of ROS which were obviously increased by MITD1 knockdown in ccRCC cells (Figure 6(c) and Supplementary Figure 1C). This evidence concerns the gene MITD1 and nonpapillary renal cell carcinoma.